Background: Sleep disturbance in persons with multiple sclerosis (pwMS) is associated with fatigue, depression, future cognitive decline, and worse quality …
Read MoreBackground: Sleep disturbance in persons with multiple sclerosis (pwMS) is associated with fatigue, depression, future cognitive decline, and worse quality …
Read MoreBackground: Nabiximols is a complex botanical mixture containing delta-9-tetrahydrocannibinol (THC), cannabidiol (CBD), other plant-derived cannabinoids, and non-cannabinoid constituents. It reduced …
Read MoreBackground: The North American Research Committee on Multiple Sclerosis (NARCOMS) registry is a voluntary, self-report registry for people with MS …
Read MoreBackground: Recent data have shown that PwMS may use cannabis to treat their complex symptoms, most frequently spasticity, pain, and …
Read MoreBackground: Depression is the most common symptom in Multiple Sclerosis (MS) patients with reported lifetime prevalence of 25-50%. Undetected and …
Read MoreBackground: Arbaclofen, the active R-enantiomer of baclofen, a racemic g-aminobutyric acid-B (GABAB) receptor agonist, has been a mainstay of treatment …
Read MoreBackground: Despite pharmacologic therapy, people with multiple sclerosis (MS) often experience spasticity, which can worsen with longer disease duration and …
Read MoreBackground: Individuals with Multiple Sclerosis (iMS) have increased postural sway and are at higher risk for falls. Some iMS describe …
Read MoreBackground: Arbaclofen is the active R-enantiomer of racemic baclofen. Arbaclofen extended-release (ER) tablets have demonstrated efficacy and safety in two …
Read MoreBackground: Fatigue is a common symptom in patients with Multiple Sclerosis (MS). Payor databases represent an important source of real …
Read MoreBackground: Evidence suggests that people with multiple sclerosis and spasticity (pwMSS) experience multiple concurrent symptoms that negatively impact daily functioning …
Read More3 University Plaza Drive, Ste 116
Hackensack, NJ 07601
(201) 487-1050
info@mscare.org
© 2021 CMSC